Search

everythinglearnresearchcommunity

for

Search:↓

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Testosterone is crucial for development, growth, and various body functions in mammals.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Public interest in oral minoxidil for hair loss increased after a New York Times article.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

TH07 treatment is promising for hair growth, with higher satisfaction in males.

3D bioprinting is advancing in plastic and reconstructive surgery, especially for creating tissues and improving surgical planning, but faces challenges like vascularization and material development.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.